February 2, 2018 / 4:18 AM / 10 months ago

BRIEF- I'rom Group unit ID Pharma signs iPS cell generation technology licensing agreement with U.S.-based QurAlis

Feb 2(Reuters) - I’rom Group Co Ltd

* Says its wholly owned unit ID Pharma concluded an iPS cell generation technology licensing agreement with U.S.-based QurAlis Corporation

Source text in Japanese:goo.gl/a2Qms7

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below